Evidence map›Paper›PMID 36235617›Full record

ArticleNutrients2022

Trimethylamine

Laurent Coulbault, Alice Laniepce, Shailendra Segobin, Céline Boudehent, Nicolas Cabé, Anne Lise Pitel

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease.American journal of physiology. Gastrointestinal and liver physiology · 2023
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Laurent CoulbaultPhysiopathology and Imaging of Neurological Disorder (PhIND), Cyceron, Institut National de la Santé et de la Recherche Biomédicale (INSERM), Institut Blood and Brain @ Caen Normandie, Normandie University, Université de Caen (UNICAEN), 14000 Caen, France.
Alice LaniepceCentre de Recherche sur les Fonctionnements et Dysfonctionnements psychologiques (CRFDP, EA7475), Normandie University, Université de Rouen (UNIROUEN), 76000 Rouen, France.ORCID 0000-0001-5421-7182
Shailendra SegobinPhysiopathology and Imaging of Neurological Disorder (PhIND), Cyceron, Institut National de la Santé et de la Recherche Biomédicale (INSERM), Institut Blood and Brain @ Caen Normandie, Normandie University, Université de Caen (UNICAEN), 14000 Caen, France.
Céline BoudehentAddictology Department, Caen University Hospital, 14000 Caen, France.
Nicolas CabéPhysiopathology and Imaging of Neurological Disorder (PhIND), Cyceron, Institut National de la Santé et de la Recherche Biomédicale (INSERM), Institut Blood and Brain @ Caen Normandie, Normandie University, Université de Caen (UNICAEN), 14000 Caen, France.ORCID 0000-0002-8051-0742
Anne Lise PitelPhysiopathology and Imaging of Neurological Disorder (PhIND), Cyceron, Institut National de la Santé et de la Recherche Biomédicale (INSERM), Institut Blood and Brain @ Caen Normandie, Normandie University, Université de Caen (UNICAEN), 14000 Caen, France.
Inserm · FRNormandie Université · FRUniversité de Caen Normandie · FR

Funding

Agence Nationale pour la Recherche RPV10004EEAConseil Régional de Basse-Normandie RPH10015EEAMission Interministérielle de Lutte contre les Drogues et les Conduites Addictives RPE10001EEA
6 · The paper itself

Abstract

backgroundTrimethylamine

methodsTMAO and IS were quantified in thirty AUD inpatients and fifteen healthy controls (HC). The severities of AUD and alcohol withdrawal syndrome (AWS), and general cognitive abilities were assessed in AUD patients.

resultsTMAO concentrations did not differ between HC and AUD patients. Several biomarkers assessing nutritional status and liver function were significantly different in AUD patients with the lowest TMAO concentrations compared to other AUD patients. IS concentration was significantly lower in AUD patients and a significant positive predictor of serum prealbumin variation during the acute phase of alcohol withdrawal. No relationship was observed between the concentrations of these metabolites and the severities of alcohol dependence, AWS, or cognitive deficits.

conclusionsOur data suggest that AUD patients with low concentrations of TMAO or IS should probably benefit from a personalized refeeding program during the acute phase of alcohol withdrawal.

Indexed as

AlcoholismSubstance Withdrawal SyndromeBiomarkersHumansIndicanMethylaminesPrealbuminBiomarkersIndicanMethylaminesPrealbumintrimethyloxaminealcoholalcohol used disordercognitionindoxyl sulfatelivertrimethylamine N-oxide

Identifiers

PMID36235617
PMCPMC9572718
OpenAlexW4297238111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.